138 related articles for article (PubMed ID: 31780804)
1. Full title: High glucose protects mesenchymal stem cells from metformin-induced apoptosis through the AMPK-mediated mTOR pathway.
He X; Yang Y; Yao MW; Ren TT; Guo W; Li L; Xu X
Sci Rep; 2019 Nov; 9(1):17764. PubMed ID: 31780804
[TBL] [Abstract][Full Text] [Related]
2. Metformin induces apoptosis in mesenchymal stromal cells and dampens their therapeutic efficacy in infarcted myocardium.
He X; Yao MW; Zhu M; Liang DL; Guo W; Yang Y; Zhao RS; Ren TT; Ao X; Wang W; Zeng CY; Liang HP; Jiang DP; Yu J; Xu X
Stem Cell Res Ther; 2018 Nov; 9(1):306. PubMed ID: 30409193
[TBL] [Abstract][Full Text] [Related]
3. Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms.
Chen SC; Brooks R; Houskeeper J; Bremner SK; Dunlop J; Viollet B; Logan PJ; Salt IP; Ahmed SF; Yarwood SJ
Mol Cell Endocrinol; 2017 Jan; 440():57-68. PubMed ID: 27856330
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and application of metformin in kidney diseases: An update.
Song A; Zhang C; Meng X
Biomed Pharmacother; 2021 Jun; 138():111454. PubMed ID: 33714781
[TBL] [Abstract][Full Text] [Related]
5. The role of AMPK/mTOR signaling pathway in anticancer activity of metformin.
Chomanicova N; Gazova A; Adamickova A; Valaskova S; Kyselovic J
Physiol Res; 2021 Aug; 70(4):501-508. PubMed ID: 34062070
[TBL] [Abstract][Full Text] [Related]
6. Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress.
Zhao M; Li XW; Chen Z; Hao F; Tao SX; Yu HY; Cheng R; Liu H
Med Sci Monit; 2019 Mar; 25():2186-2194. PubMed ID: 30905926
[TBL] [Abstract][Full Text] [Related]
7. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.
Langer S; Kreutz R; Eisenreich A
J Nephrol; 2016 Dec; 29(6):765-773. PubMed ID: 26733332
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
9. Metformin attenuates albumin-induced alterations in renal tubular cells in vitro.
Allouch S; Munusamy S
J Cell Physiol; 2017 Dec; 232(12):3652-3663. PubMed ID: 28158902
[TBL] [Abstract][Full Text] [Related]
10. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.
Eisenreich A; Leppert U
Curr Med Chem; 2017; 24(31):3397-3412. PubMed ID: 28393693
[TBL] [Abstract][Full Text] [Related]
11. New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway.
Hsu SK; Cheng KC; Mgbeahuruike MO; Lin YH; Wu CY; Wang HD; Yen CH; Chiu CC; Sheu SJ
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502359
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial targets of metformin-Are they physiologically relevant?
Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
[TBL] [Abstract][Full Text] [Related]
13. mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Kezic A; Popovic L; Lalic K
Oxid Med Cell Longev; 2018; 2018():2640342. PubMed ID: 30034573
[TBL] [Abstract][Full Text] [Related]
14. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
Lv Y; Tian N; Wang J; Yang M; Kong L
J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.
Wu XB; Liu Y; Wang GH; Xu X; Cai Y; Wang HY; Li YQ; Meng HF; Dai F; Jin JD
Sci Rep; 2016 Feb; 6():21420. PubMed ID: 26892992
[TBL] [Abstract][Full Text] [Related]
16. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS
J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524
[TBL] [Abstract][Full Text] [Related]
17. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
[TBL] [Abstract][Full Text] [Related]
18. Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice.
Zheng S; Liu J; Han Q; Huang S; Su W; Fu J; Jia X; Du S; Zhou Y; Zhang X; Guan Y
J Diabetes; 2014 Mar; 6(2):132-46. PubMed ID: 24405721
[TBL] [Abstract][Full Text] [Related]
19. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
20. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice.
Yu JW; Deng YP; Han X; Ren GF; Cai J; Jiang GJ
Cardiovasc Diabetol; 2016 Jun; 15():88. PubMed ID: 27316923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
